Skip to Content

Bcworldpharm Co Ltd 200780

Morningstar Rating
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

200780 is trading at a 33% discount.
Price
KRW 6,882.57
Fair Value
KRW 38,272.88
Uncertainty
Very High
1-Star Price
KRW 83,629.29
5-Star Price
KRW 9,355.41
Economic Moat
Vbdxq
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 200780 is a good fit for your portfolio.

Trading Information

Previous Close Price
Day Range
KRW 6,710.006,850.00
52-Week Range
Bid/Ask
KRW 6,840.00 / KRW 6,760.00
Market Cap
KRW 56.88 Bil
Volume/Avg
7,175 / 15,094

Key Statistics

Price/Earnings (Normalized)
21.84
Price/Sales
0.77
Dividend Yield (Trailing)
1.46%
Dividend Yield (Forward)
1.46%
Total Yield
1.46%

Company Profile

Bcworldpharm Co Ltd is a pharmaceutical company. The Company's products include Anti-TB, Anti-Diabetic, Analgesics, Narcotics Antidotes and Hemostatics. The products are offered under ALIMA Inj, AROXOL Tab, ASCORBIC Inj and BC CITICOLINE Inj brands.
Sector
Healthcare
Industry
Drug Manufacturers - General
Stock Style Box
Small Value
Total Number of Employees
285

Comparables

Valuation

Metric
200780
000640
140410
Price/Earnings (Normalized)
21.8421.48
Price/Book Value
0.710.7322.58
Price/Sales
0.770.6535.00
Price/Cash Flow
5.295.37
Price/Earnings
200780
000640
140410

Financial Strength

Metric
200780
000640
140410
Quick Ratio
0.330.442.17
Current Ratio
0.520.662.51
Interest Coverage
1.203.70−43.24
Quick Ratio
200780
000640
140410

Profitability

Metric
200780
000640
140410
Return on Assets (Normalized)
1.57%3.28%−17.65%
Return on Equity (Normalized)
3.53%6.15%−33.91%
Return on Invested Capital (Normalized)
3.90%4.65%−28.13%
Return on Assets
200780
000640
140410
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - General Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
LLY
Eli Lilly and CoPcnfhllnnVkbml$739.7 Bil
JNJ
Johnson & JohnsonCcwnfpnbCzdys$381.2 Bil
MRK
Merck & Co IncZpvkjzfxSppc$334.2 Bil
ABBV
AbbVie IncWkdlbytvGdycv$322.4 Bil
AZN
AstraZeneca PLC ADRDwcqpmygtRqtq$208.8 Bil
RHHBY
Roche Holding AG ADRPpxqltwqkmNgfg$203.8 Bil
PFE
Pfizer IncSntscflhBkmq$157.1 Bil
AMGN
Amgen IncDzjkvwhjhGbph$152.4 Bil
SNY
Sanofi SA ADRNhsrscwnzDhftp$122.8 Bil
BMY
Bristol-Myers Squibb CoFglbswckCktn$109.7 Bil

Sponsor Center